BioVersys completes BV100 Phase 1 clinical trial in China
The completion of this mandatory Phase 1 safety and pharmacokinetic clinical trial in China is crucial in the development of…
BEAM at work
Our advocacy work is based on analysis and reflection with our members.
Each topic is dealt with by a task force, which acts as a discussion platform and issues policy briefs.
